{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:38:12Z","timestamp":1756384692273,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>Each year in the UK, around 1 in 5,000 people develops Bell\u2019s palsy \u2013 idiopathic unilateral lower motor neurone facial weakness of rapid onset.1 Of those who are not treated, about 16% end up with permanent moderate to severe weakness, which can result in facial dysfunction and disfigurement, and psychological difficulties.2<jats:sup>\u2013<\/jats:sup>5 There has been longstanding controversy about what, if any, treatment should be given, with potential alternatives including corticosteroids, antiviral drugs, acupuncture and physiotherapy.6 We last reviewed this condition in 2006, indicating that \u201cpublished trials on the efficacy of drug treatments have been poor and no firm conclusions can be drawn about the benefit of any single drug\u201d, and \u201cit is unclear what place, if any, acupuncture and physiotherapy have in the management of patients with Bell\u2019s palsy\u201d.6 Here we update our conclusions in the light of recently published evidence.<\/jats:p>","DOI":"10.1136\/dtb.2008.06.0015","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T17:17:33Z","timestamp":1215191853000},"page":"53-54","source":"Crossref","is-referenced-by-count":3,"title":["Update on managing Bell\u2019s palsy"],"prefix":"10.1136","volume":"46","member":"239","published-online":{"date-parts":[[2008,7,4]]},"reference":[{"key":"2025082700141111000_46.7.53.1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1468-1331.2002.00343.x","article-title":"The epidemiology and treatment of Bell\u2019s palsy in the UK.","volume":"9","author":"Rowlands","year":"2002","journal-title":"Eur J Neurol"},{"key":"2025082700141111000_46.7.53.2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00343.x"},{"key":"2025082700141111000_46.7.53.3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.MLG.0000157694.57872.82","article-title":"Clinical factors that influence the prognosis of facial nerve paralysis and the magnitudes of influence.","volume":"115","author":"Ikeda","year":"2005","journal-title":"Laryngoscope"},{"key":"2025082700141111000_46.7.53.4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/000164802760370736","article-title":"Bell\u2019s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies.","volume":"549","author":"Peitersen","year":"2002","journal-title":"Acta Otolaryngol Suppl"},{"key":"2025082700141111000_46.7.53.5","first-page":"340","article-title":"Defining functional limitation, disability, and societal limitations in patients with facial paresis: initial pilot questionnaire.","volume":"17","author":"Neely","year":"1996","journal-title":"Am J Otol"},{"key":"2025082700141111000_46.7.53.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(96)90022-8"},{"key":"2025082700141111000_46.7.53.7","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2006.44749"},{"key":"2025082700141111000_46.7.53.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe078188"},{"key":"2025082700141111000_46.7.53.9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00129492-200207000-00037","article-title":"Idiopathic facial paralysis (Bell\u2019s palsy).","volume":"23","author":"Gacek","year":"2002","journal-title":"Otol Neurotol"},{"key":"2025082700141111000_46.7.53.10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.1975.03260060037015","article-title":"Herpes simplex virus in idiopathic facial paralysis (Bell palsy).","volume":"233","author":"Adour","year":"1975","journal-title":"JAMA"},{"key":"2025082700141111000_46.7.53.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03260060037015"},{"key":"2025082700141111000_46.7.53.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1980.tb00895.x"},{"key":"2025082700141111000_46.7.53.13","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1981.00790380009003"},{"key":"2025082700141111000_46.7.53.14","doi-asserted-by":"publisher","DOI":"10.3109\/00016488809107364"},{"key":"2025082700141111000_46.7.53.15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00005","article-title":"Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle.","volume":"124","author":"Murakami","year":"1996","journal-title":"Ann Int Med"},{"key":"2025082700141111000_46.7.53.16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00005"},{"key":"2025082700141111000_46.7.53.17","first-page":"307","article-title":"Prednisolone or acyclovir in Bell\u2019s palsy: the authors\u2019 reply.","volume":"358","author":"Sullivan","year":"2008","journal-title":"N Engl J Med"},{"key":"2025082700141111000_46.7.53.18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.survophthal.2006.12.009","article-title":"Ophthalmic management of facial nerve palsy: a review.","volume":"52","author":"Rahman","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"2025082700141111000_46.7.53.19","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa072006","article-title":"Early treatment with prednisolone or acyclovir in Bell\u2019s palsy.","volume":"357","author":"Sullivan","year":"2007","journal-title":"N Engl J Med"},{"key":"2025082700141111000_46.7.53.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072006"},{"key":"2025082700141111000_46.7.53.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000248737.65607.9e"},{"key":"2025082700141111000_46.7.53.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000265190.29969.12"},{"key":"2025082700141111000_46.7.53.23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002914.pub3"},{"key":"2025082700141111000_46.7.53.24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0269215507070790","article-title":"Effect of facial neuromuscular re-education on facial symmetry in patients with Bell\u2019s palsy: a randomized controlled trial.","volume":"21","author":"Manikandan","year":"2007","journal-title":"Clin Rehabil"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2008.06.0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:14:21Z","timestamp":1756278861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2008.06.0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,7,4]]},"published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1136\/dtb.2008.06.0015"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2008.06.0015","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}